Literature DB >> 19813197

Non-lethal neonatal neuromuscular variant of glycogenosis type IV with novel GBE1 mutations.

Carla Fernandez1, Cécile Halbert, André Maues De Paula, Valerié Lacroze, Roseline Froissart, Dominique Figarella-Branger, Brigitte Chabrol, Jean-François Pellissier.   

Abstract

We report a recent case of the severe congenital variant of glycogen storage disease type IV with prolonged survival. The patient was found to be a compound heterozygote for two novel mutations, a missense mutation in exon 5 (p.H188P, c.563A>C) and a severe mutation in intron 5 (c.691+2T>C). We propose that the genotype and the quality of medical care may account for the severe but non-lethal phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19813197     DOI: 10.1002/mus.21499

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities.

Authors:  Rainer Malik; Nathalie Beaufort; Simon Frerich; Benno Gesierich; Marios K Georgakis; Kristiina Rannikmäe; Amy C Ferguson; Christof Haffner; Matthew Traylor; Michael Ehrmann; Cathie L M Sudlow; Martin Dichgans
Journal:  Brain       Date:  2021-10-22       Impact factor: 15.255

2.  Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy.

Authors:  Marius Kuhn; Dieter Gläser; Pushpa Raj Joshi; Stephan Zierz; Stephan Wenninger; Benedikt Schoser; Marcus Deschauer
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

3.  Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review.

Authors:  Hiroyuki Iijima; Reiko Iwano; Yukichi Tanaka; Koji Muroya; Tokiko Fukuda; Hideo Sugie; Kenji Kurosawa; Masanori Adachi
Journal:  Mol Genet Metab Rep       Date:  2018-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.